Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 4, 1997, Pages 456-460

  Khan, B ^a,e   Omar, S ^a   Kanyara, J N ^a   Warren Perry, M ^b   Nyalwidhe, J ^a   Peterson, D S ^c   Wellems, T ^c   Kaniaru, S ^a   Gitonga, J ^a   Mulaa, F J ^d   Koech, D K ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Chlorcycloguanil; Cycloguanil; Dihydrofolate reductase gene; Drug resistance; Kenya; Malaria; Plasmodium falciparum; Point mutation; Pyrimethamine

Indexed keywords

4 AMINOBENZOIC ACID; ANTIMALARIAL AGENT; CHLORCYCLOGUANIL; CHLOROQUINE; CHLORPROGUANIL; CYCLOGUANIL; DAPSONE; DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; PYRIMETHAMINE; SULFANILAMIDE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; KENYA; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION;

PLASMODIUM FALCIPARUM;

EID: 12644310315     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90284-4     Document Type: Article

References (20)

1. Avery Jones, S. (1958). Mass treatment with pyrimethamine. A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya. September 1952-September 1953. Transactions of the Royal Society of Tropical Medicine and Hygiene, 52, 547-561.
2. Björkman, A., Brohult, J., Sirleaf, V., Willcox, M. & Bengstsson, E. (1980). Plasmodium falciparum resistant to pyrimethamine and chlorproguanil - host or parasite dependent? Annals of Tropical Medicine and Parasitohgy, 74, 245-248.
3. Bzik, D. J., Li, W., Horri, T. & Inselberg, J. (1987). Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proceedings of the National Academy of Sciences of the USA, 84, 8360-8364.
4. Chulay, J. D., Watkins, W. M. & Sixsmith, D. G. (1984). Synergistic antimalarial activity of pyrimethamine and sulphadoxine against Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene, 33, 325-330.
5. Cowman, A. F., Morry, M. J., Biggs, B. A., Cross, G. A. M. & Foote, S. J. (1988). Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the USA, 85, 9109-9113.
6. Desjardins, R. E., Canfield, C. J., Haynes, J. D. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710-718.
7. Foote, S. J., Galatis, D. & Cowman, A. F. (1990). Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the USA, 87, 3014-3017.
8. Gyang, F. N., Peterson, D. S. & Wellems,T. E. (1992). Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. Experimental Parasitology, 74, 470-472.
9. Haynes, J. D., Diggs, C. L., Hines, F. A. & Desjardins, R. E. (1976). Culture of human malaria parasites Plasmodium falciparum. Nature, 263, 767-769.
10. Nguyen-Dinh, P., Spencer, H. C., Masaba, S. C. & Churchill, F. C. (1982). Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya. Lancet, i, 823-825.
11. Peterson, D. S.,Walliker, D. & Wellems,T. E. (1988). Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences of the USA, 85, 9114-9118.
12. Peterson, D. S., Milhous, W. K. & Wellems, T. E. (1990). Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the USA, 87, 3018-3022.
13. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A. & Arnheim, N. (1985). Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230, 1350-1354.
14. Snewin, V. A., England, S. M., Sims, P. F. G. & Hyde, J. E. (1989). Characterization of the dihydrofolate reductase-thymidylate synthase gene from human malaria parasites highly resistant to pyrimethamine. Gene, 76, 41-52.
15. Thaithong, S., Chan, S., Songsomboon, S., Wilairat, P., Seesod, N., Sueblinwong, T., Goman, M., Ridley, R. & Beale, G. (1992). Pyrimethamine resistant mutations in Plasmodium falciparum. Molecular and Biochemical Parasitology, 52, 149-158.
16. Trager, W. & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science, 193, 673-675.
17. Watkins, W. M., Howells, R. E., Brandling-Bennett, A. D. & Koech, D. K. (1987). In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya, to antimalarial drugs. American Journal of Tropical Medicine and Hygiene, 37, 445-451.
18. Watkins,W. M., Brandling-Bennett, A. D., Nevill, C. G., Carter, J. Y., Boriga, D. A., Howells, R. E. & Koech, D. K. (1988). Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum malaria in Kenya: a pilot study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 398-403.
19. Wu, Y., Kirkman, L. A. & Wellems, E. (1996). Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proceedings of the National Academy of Sciences of the USA, 93, 1130-1134.
20. Zolg, J. W, Chen, G. & Plitt, J. R. (1990). Detection of pyrimethamine resistance in Plasmodium falciparum by mutation-specific polymerase chain reaction. Molecular and Biochemical Parasitology, 39, 257-265.